查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606557

全球智慧帮浦市场 - 2024-2031

Global Smart Pumps Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球智慧型帮浦市场规模达94亿美元，预计2031年将达到167亿美元，2024-2031年预测期间复合年增长率为7.5%。

智慧型帮浦是技术先进的医疗设备，旨在透过静脉 (IV)、肠内或其他输送途径准确、安全地向患者输送液体、药物或营养物质。这些帮浦整合了智慧软体、感测器和连接功能，以提高精度、减少错误并优化患者护理。医疗保健中的智慧型帮浦代表了医疗技术的重大进步，能够精确、安全和高效地提供关键治疗，其应用范围从重症监护病房到家庭医疗保健环境。

医疗保健领域的智慧帮浦市场正在迅速扩大。这种增长是由于对剂量误差减少软体和智慧整合功能等患者安全功能的需求增加而推动的。例如，根据美国国立卫生研究院的数据，根据美国卫生系统药剂师协会 (ASHP) 的一项调查，美国 89.5% 的医院使用了智慧帮浦技术。智慧泵技术的使用因床位大小而异，在600张床位及以上的医院全面实施。

此外，根据美国国立卫生研究院进行的研究，使用智慧帮浦记录，对 IV 级 NICU 住院的新生儿和婴儿连续输注药物的超过 370,000 次输注开始进行了评估。智慧型帮浦阻止了 160 次超过最大剂量硬性最大限制的尝试，剂量高达最大剂量的 7-29 倍，并导致在软最大警报后重新编程或取消 2093 次输注。

市场动态：

驱动程式和限制

家庭医疗保健需求不断增长

家庭医疗保健需求的不断增长正在显着推动智慧帮浦市场的成长，预计将在预测期内透过增加对可在医院环境外使用的可靠、准确和远端管理的医疗设备的需求来推动市场。随着全球人口老化，糖尿病、心臟病和肾衰竭等慢性病的盛行率越来越高。这些病症通常需要长期治疗，例如胰岛素输送、肠外营养和透过输液帮浦控制疼痛。智慧型帮浦能够提供准确的剂量和即时监控，非常适合家庭使用。

据世界卫生组织称，全球约有 8.3 亿人患有糖尿病，其中大多数生活在低收入和中等收入国家。糖尿病患者人数从1990年的2亿增加到2022年的8.3亿。此外，约11%的心血管死亡是由高血糖引起的。糖尿病的上升可能会增加对胰岛素帮浦的需求，因此，对家用智慧帮浦的需求不断增加。

例如，根据美国国立卫生研究院的数据，在 22 个月内，胰岛素帮浦的使用率从 45% 增加到 58%，这是一个显着的改善。包括胰岛素帮浦在内的糖尿病技术的使用与改善血糖控制有关，特别是对于患有第 1 型糖尿病的青少年。这进一步增加了对有助于在家中管理胰岛素水平的智慧帮浦的需求。

以患者为中心的护理和家庭医院计划的趋势正在推动智慧泵的采用。医疗保健提供者越来越多地允许患者在家中管理治疗，从而减少医院就诊次数和费用。例如，接受化疗、家庭肠外营养或持续胰岛素治疗的患者可以使用智慧帮浦安全地进行治疗，同时由医疗保健专业人员进行远端监控。

例如，根据医疗保险和医疗补助服务中心 (CMS) 精算师办公室的分析，美国家庭医疗保健支出近 1,030 亿美元，到 2026 年，这一数字将达到近 1,730 亿美元。这一增长是由门诊护理的推动、医疗保健成本的增加以及家庭医疗设备的改进所推动的。

营运和用户挑战

营运和用户挑战预计将阻碍智慧泵市场的成长。儘管它们具有先进的功能和显着的优势，但这些挑战阻碍了广泛采用，特别是在医院、诊所和家庭环境等复杂的医疗环境中。智慧型帮浦具有复杂的功能，例如剂量误差减少软体、远端监控以及与医院系统的整合。这些功能需要更高层次的技术知识才能有效运作。例如，设计用于药物输送的泵，例如用于化疗或胰岛素的泵，可能具有复杂的设置，可能会让未经充分培训的医疗保健专业人员不知所措。

此外，在医院中，一些医务人员报告说，在操作智慧泵时，尤其是从传统泵切换时，学习曲线很陡峭。这增加了最初过渡期间出现人为错误的可能性，从而阻碍设施全面采用智慧泵技术。

在某些情况下，医院的智慧输液帮浦和药物管理系统面临整合挑战。跨设备和系统缺乏标准化协议意味着将这些设备与现有基础设施连接可能既耗时又昂贵。例如，根据大学健康系统 (UHS) 的数据，智慧帮浦的价格为 1,200 至 1,300 美元。一项设定的成本通常在 3,000 美元到 4,000 美元之间，其中包括软体授权成本。在库存的 7,000 个 IV 泵浦中，UHS 拥有约 1,800 至 2,400 个智慧泵浦。

目录

第一章：市场介绍和范围

  • 报告的目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分類的片段
  • 连结性片段
  • 按应用程式片段
  • 最终使用者的片段
  • 按地区分類的片段

第 3 章：动力学

  • 影响因素
    • 司机
      • 家庭医疗保健需求不断增长
      • 不断进步的技术
    • 限制
      • 营运和用户挑战
    • 机会
    • 影响分析

第 4 章：策略洞察与产业展望

  • 市场领导者和先驱
    • 新兴先锋和杰出参与者
    • 拥有最畅销品牌的知名领导者
    • 拥有成熟产品的市场领导者
  • 新兴新创企业和关键创新者
  • CXO 观点
  • 最新进展和突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：智慧帮浦市场，依产品类型

  • 输液智慧泵
  • 智慧饲餵泵
  • 专用泵浦

第 6 章：智慧型帮浦市场（依连接性）

  • 独立泵浦
  • 连接帮浦
    • 有线连接
    • 无线连线

第 7 章：智慧帮浦市场（按应用）

  • 药物输送
  • 化疗
  • 疼痛管理
  • 糖尿病管理
  • 新生儿和儿科护理
  • 其他的

第 8 章：智慧帮浦市场（按最终用户）

  • 医院
  • 专科诊所
  • 门诊手术中心
  • 家庭护理设置

第 9 章：智慧帮浦市场，按区域市场分析与成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的主要发展
  • 公司基准化分析

第 11 章：公司简介

  • B. Braun Medical Inc.
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
    • SWOT分析
  • Medtronic plc
  • Fresenius Kabi USA, LLC
  • Terumo Corporation
  • Becton, Dickinson and Company
  • ICU Medical, Inc.
  • Baxter International Inc.
  • Insulet Corporation
  • BPL Medical Technologies
  • SINO MDT (LIST NOT EXHAUSTIVE)

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: MD8861

Overview

The global smart pumps market reached US$ 9.4 billion in 2023 and is expected to reach US$ 16.7 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031.

Smart pumps are technologically advanced medical devices designed to accurately and safely deliver fluids, medications or nutrients to patients through intravenous (IV), enteral or other delivery routes. These pumps integrate intelligent software, sensors and connectivity features to enhance precision, reduce errors and optimize patient care. Smart pumps in healthcare represent a significant advancement in medical technology, enabling precise, safe and efficient delivery of critical therapies, with applications ranging from critical care units to home healthcare environments.

The smart pump market in healthcare is expanding rapidly. This growth is fueled by increased demand for patient safety features like dose error reduction software and smart integration capabilities. For instance, according to the National Institute of Health, 89.5% of hospitals in the United States used smart pump technology according to a survey developed by the American Society of Health-System Pharmacists (ASHP). The utilization of smart pump technology varied by hospital bed size with full implementation in hospitals with 600 beds and more.

Additionally, according to the study conducted by the National Institute of Health, using smart pump records, over 370,000 infusion starts for continuously infused medications used in neonates and infants hospitalized in a level IV NICU were evaluated. Smart pumps prevented 160 attempts to exceed the hard maximum limit for doses that were as high as 7-29 times the maximum dose and resulted in the reprogramming or cancellation of 2093 infusions after soft maximum alerts.

Market Dynamics: Drivers & Restraints

Rising demand for home healthcare

Rising demand for home healthcare is significantly driving the growth of the smart pumps market and is expected to drive the market over the forecast period by increasing the need for reliable, accurate and remotely manageable medical devices that can be used outside of hospital settings. As the global population ages, there is a higher prevalence of chronic conditions such as diabetes, heart disease and kidney failure. These conditions often require long-term treatments such as insulin delivery, parenteral nutrition and pain management through infusion pumps. Smart pumps, with their ability to provide accurate dosing and real-time monitoring, are ideal for home use.

According to the World Health Organization, about 830 million people worldwide have diabetes, the majority living in low-and middle-income countries. The number of people living with diabetes rose from 200 million in 1990 to 830 million in 2022. In 2021, diabetes and kidney disease due to diabetes caused over 2 million deaths. In addition, around 11% of cardiovascular deaths were caused by high blood glucose. This rising diabetes may increase the demand for insulin pumps, thus, there is an increasing demand for smart pumps to use at home.

For instance, according to the National Institute of Health, over 22 months, insulin pump use rates increased from 45 to 58%, a significant improvement. Use of diabetes technology, including insulin pumps, has been associated with improved glycemic control, particularly in youths with type 1 diabetes. This further increases the demand for smart pumps which helps to manage insulin levels at home.

The trend toward patient-centric care and hospital-at-home programs is fueling the adoption of smart pumps. Healthcare providers are increasingly allowing patients to manage their treatments at home, reducing hospital visits and costs. For instance, patients receiving chemotherapy, home parenteral nutrition or continuous insulin therapy can use smart pumps to safely administer their treatments while being monitored remotely by healthcare professionals.

For instance, almost $103 billion was spent on home health care in the United States and that number will reach nearly $173 billion by 2026, according to an analysis from the Centers for Medicare & Medicaid Services (CMS) Office of the Actuary. This growth is driven by the push for outpatient care, increasing healthcare costs and improvements in home-based medical devices.

Operational and user challenges

Operational and user challenges are expected to hamper the growth of the smart pumps market. Despite their advanced features and significant benefits, these challenges hinder widespread adoption, particularly in complex healthcare environments like hospitals, clinics, and home settings. Smart pumps come with sophisticated features like dose error reduction software, remote monitoring and integration with hospital systems. These features require a higher level of technical knowledge to operate effectively. For instance, pumps designed for drug delivery, such as those for chemotherapy or insulin, may have intricate settings that can overwhelm healthcare professionals without adequate training.

Additionally, in hospitals, some medical staff report a steep learning curve when it comes to handling smart pumps, especially when switching from traditional pumps. This increases the likelihood of human errors during the initial transition period, which can discourage facilities from fully adopting smart pump technologies.

In some instances, hospitals have faced integration challenges with their smart infusion pumps and medication administration systems. The lack of standardized protocols across devices and systems means that connecting these devices with existing infrastructure can be time-consuming and costly. For instance, according to the University Health System (UHS), smart pumps can run $1,200 to $1,300. One setup typically falls within a cost range of $3,000 to $4,000, including the software license cost. Of the 7,000 IV pumps in inventory, UHS had about 1,800 to 2,400 smart pumps.

Segment Analysis

The global smart pumps market is segmented based on product type, connectivity, application, end-user and region.

Product Type:

The infusion smart pumps segment is expected to dominate the smart pumps market share

The infusion smart pumps segment is expected to dominate the global smart pumps market. Infusion pumps are used extensively across various healthcare settings, including hospitals, clinics and home care environments. These devices are essential for drug delivery, parenteral nutrition, chemotherapy and insulin therapy, among other treatments.

Infusion smart pumps incorporate advanced dose error reduction systems, wireless connectivity, dose safety software and real-time monitoring, which enhances their safety and efficiency. These innovations help reduce medication errors, a significant concern in healthcare.

For instance, in April 2024, Baxter International Inc. cleared the U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform, which includes Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software, powered by the IQ Enterprise Connectivity Suite, enables clinicians to utilize a single, integrated system across a variety of patient care settings.

As more patients prefer managing their treatments at home, the need for portable infusion pumps has increased. Smart pumps allow for remote monitoring and data sharing, which are crucial for home healthcare settings, especially for chronic patients requiring ongoing infusion therapy.

Geographical Analysis

North America is expected to hold a significant position in the smart pumps market share

North America is expected to hold the largest market share in the global smart pumps market. North America, especially the United States is home to leading manufacturers of smart pumps, including Medtronic, Baxter International and other emerging players, which are continuously innovating to develop advanced, user-friendly smart pumps. These innovations, such as wireless connectivity, real-time monitoring and cloud-based data analytics, make these devices highly desirable in the healthcare industry.

For instance, in June 2023, B. Braun Medical Inc. launched its next generation of infusion management software, DoseTrac Enterprise Infusion Management Software. With this new software, organizations receive a mix of real-time views and retrospective reporting features to better understand their infusion pump fleet and associated data. The DoseTrac Enterprise Software platform can also connect up to 40,000 pumps at an unlimited number of facilities with just one application.

North America has a high prevalence of chronic diseases like diabetes, heart disease and cancer, which require continuous medication administration via infusion pumps. This has fueled the demand for smart pumps, especially for insulin infusion pumps and chemotherapy drug delivery systems. For instance, according to the American Diabetes Association, 38.4 million Americans, or 11.6% of the population, have diabetes, many of whom rely on infusion pumps for insulin delivery. The growing patient population is a significant driver for the smart infusion pump market.

Asia-Pacific is growing at the fastest pace in the smart pumps market

The Asia-Pacific region is experiencing the fastest growth in the smart pumps market. There has been a rapid increase in the adoption of smart healthcare devices in the Asia Pacific region. This is partly driven by the growing need for remote monitoring, dose error reduction and patient safety in hospitals and home care settings. Major market players in this region especially China, India and Japan focusing on smart infusion pumps with integrated technologies that allow for wireless communication, real-time data sharing and remote patient monitoring are seeing a surge in demand.

For instance, in February 2023 Mindray launched its BeneFusion i Series and u Series infusion systems featuring high precision, adaptive customization and extraordinary simplicity for guaranteed levels of medication safety in a variety of clinical settings. The new generation of smart pumps, for their advanced features to reduce medication errors, streamline workflow and improve cost-effectiveness, has seen greater potential in endoscopic, obstetrics, oncology, emergency departments and more.

Competitive Landscape

The major global players in the smart pumps market include B. Braun Medical Inc., Medtronic plc, Fresenius Kabi USA, LLC, Terumo Corporation, Becton, Dickinson and Company, ICU Medical, Inc., Baxter International Inc., Insulet Corporation, BPL Medical Technologies, SINO MDT and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global smart pumps market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Connectivity
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Demand for Home Healthcare
      • 3.1.1.2. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Operational and User Challenges
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging pioneers and prominent players
    • 4.1.2. Established leaders with largest-selling brands
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Smart Pumps Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Infusion Smart Pumps*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Smart Feeding Pumps
  • 5.4. Specialized Pumps

6. Smart Pumps Market, By Connectivity

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 6.1.2. Market Attractiveness Index, By Connectivity
  • 6.2. Standalone Pumps*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Connected Pumps
    • 6.3.1. Wired Connectivity
    • 6.3.2. Wireless Connectivity

7. Smart Pumps Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Drug Delivery*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Chemotherapy
  • 7.4. Pain Management
  • 7.5. Diabetes Management
  • 7.6. Neonatal and Pediatric Care
  • 7.7. Others

8. Smart Pumps Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Homecare Settings

9. Smart Pumps Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. B. Braun Medical Inc. *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Medtronic plc
  • 11.3. Fresenius Kabi USA, LLC
  • 11.4. Terumo Corporation
  • 11.5. Becton, Dickinson and Company
  • 11.6. ICU Medical, Inc.
  • 11.7. Baxter International Inc.
  • 11.8. Insulet Corporation
  • 11.9. BPL Medical Technologies
  • 11.10. SINO MDT (LIST NOT EXHAUSTIVE)

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us